HCM
JAZZ icon

Harvey Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Harvey Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.49M Sell
26,913
-8,407
-24% -$1.84M 1.33% 20
2026
Q1 		$6.68M Buy
35,320
+350
+1% +$61.2K 1.52% 18
2025
Q4 		$5.94M Sell
34,970
-2,805
-7% -$430K 1.27% 20
2025
Q3 		$4.98M Sell
37,775
-1,610
-4% -$193K 1.06% 25
2025
Q2 		$4.31M Buy
39,385
+13,980
+55% +$1.52M 1.01% 31
2025
Q1 		$3.15M Sell
25,405
-45
-0.2% -$5.87K 0.83% 38
2024
Q4 		$3.13M Buy
+25,450
New +$3M 0.74% 38

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Harvey Capital Management's JAZZ Position: Q2 2026 in Review

Harvey Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q2 2026, selling an estimated $1.84M and leaving 26,913 shares worth $6.49M. The position accounts for 1.33% of the portfolio, ranked #20.

Harvey Capital Management first reported a position in JAZZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.68M in Q1 2026. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Harvey Capital Management held 26,913 shares of Jazz Pharmaceuticals worth $6.49M as of Q2 2026.
  • Harvey Capital Management sold 8,407 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.84M.
  • Jazz Pharmaceuticals made up 1.33% of Harvey Capital Management's portfolio in Q2 2026, its #20 holding.
  • Harvey Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Harvey Capital Management's Jazz Pharmaceuticals position peaked at $6.68M in Q1 2026.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Harvey Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.